OpenUCT Home
→
Browsing by Author

Browsing by Author "McIlleron, H"

Now showing items 1-2 of 2

Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial

Author: Guglielmetti, L ; Ardizzoni, E ; Atger, M ; Baudin, E ; Berikova, E ; Bonnet, M ; Chang, E ; Cloez, S ; Coit, J M ; Cox, V ; de Jong, B C ; Delifer, C ; Do, J M ; Tozzi, D D S ; Ducher, V ; Ferlazzo, G ; Gouillou, M ; Khan, A ; Khan, U ; Lachenal, N ; LaHood, A N ; Lecca, L ; Mazmanian, M ; McIlleron, H ; Moschioni, M ; O’Brien, K ; Okunbor, O ; Oyewusi, L ; Panda, S ; Patil, S B ; Phillips, P P J ; Pichon, L ; Rupasinghe, P ; Rich, M L ; Saluhuddin, N ; Seung, K J ; Tamirat, M ; Trippa, L ; Cellamare, M ; Velásquez, G E ; Wasserman, S ; Zimetbaum, P J ; Varaine, F ; Mitnick, C D Date: 25 Sep 2021 Background Treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR-TB) is expensive, labour-intensive, and associated with substantial adverse events and poor outcomes. While most MDR/RR-TB patients do not receive ... Read more c b
Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected children

Author: Zhang, C ; Denti, P ; Simonsson, USH ; Maartens, Gary ; Karlsson, MO ; McIlleron, H Date: 2010 Children with HIV associated tuberculosis often require co-formulated lopinavir/ritonavir (LPV/RTV)-based antiretroviral treatment with rifampicin-based antitubercular treatment (ATT). Rifampicin (RIF), a potent inducer of drug-metabolizing ... Read more c b

Now showing items 1-2 of 2

Browse

All of OpenUCT

Browsing by Author "McIlleron, H"

Browsing by Author "McIlleron, H"

Browse

All of OpenUCT